Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

R3t@trutide + Cagrilintide 10mg

R 1,493.85
Add to WishlistCompare

Pure R3T@trutide + Cagrilintide 10 mg is a research-grade peptide blend supplied as a lyophilised powder for laboratory and scientific research applications.

This fixed-ratio research blend combines Retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, with Cagrilintide, a long-acting amylin analogue. The combination is being investigated in metabolic research involving appetite signalling, satiety, energy balance, glucose regulation and related receptor pathways.

Pure Labs lists the product as 10 mg total reference strength, 99% purity, third-party verified, and under Metabolic Research.

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

For laboratory and scientific research use only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.

Key Features

• Research Grade • 10mg reference strength • 99% Purity • Third-Party Verified • Fixed-ratio peptide blend • Retatrutide + Cagrilintide • Lyophilised powder • Metabolic research

Dosage & Usage

Product: Retatrutide + Cagrilintide 10mg
Classification: Fixed-ratio metabolic peptide blend
Components: Retatrutide + Cagrilintide
Reference Strength: 10mg total blend
Research Areas: GIP / GLP-1 / glucagon signalling, amylin receptor research, appetite regulation, metabolic and energy-balance research.

Research classification: Metabolic peptide blend / receptor pharmacology.

FAQ's & Tips

What is Retatrutide + Cagrilintide?
It is a fixed-ratio research blend combining Retatrutide and Cagrilintide.

What is the reference strength?
10mg total blend.

What is the blend researched for?
Research includes metabolic signalling, appetite regulation, satiety, glucose regulation and energy-balance pathways.

How is it supplied?
Lyophilised peptide powder for laboratory research.

What is the research category?
Metabolic Research.

Is this product intended for human use?
No. This product is supplied strictly for laboratory and scientific research.

Research

This research formulation combines retatrutide, a GIP/GLP-1/glucagon receptor agonist, with cagrilintide, a long-acting amylin analogue. Research interest centres on complementary metabolic signalling involving incretin, glucagon and amylin pathways, including appetite regulation, energy balance and glucose metabolism. Because the combination is distinct from the individual compounds, its effects should be interpreted as formulation-specific research findings rather than assumed to equal the evidence for either component alone. For laboratory research use only.

Reviews